U.S. Household Products Stock News

NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Will Harrow’s (HROW) TYRVAYA Deal and Reaffirmed 2026 Guidance Redefine Its Dry Eye Strategy?

In August 2026, Harrow, Inc. reported second-quarter revenue of US$70.66 million versus US$63.74 million a year earlier, swung to a net loss of US$17.27 million, and reiterated its 2026 revenue guidance of US$350 million to US$365 million. Just days earlier, Harrow agreed to acquire TYRVAYA nasal spray for up to US$100 million, aiming to broaden its dry eye disease franchise with a drop-free treatment that complements its existing VEVYE offering. Next, we’ll examine how reaffirmed 2026...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

Agios Pharmaceuticals (AGIO) Could Be 24% Undervalued On PYRUKYND Growth Hopes

Agios Pharmaceuticals (AGIO) has drawn investor focus after recent trading left the stock at a last close of $33.63. With mixed return figures across different periods, the company’s rare disease portfolio is gaining fresh attention. See our latest analysis for Agios Pharmaceuticals. Over the past year, Agios Pharmaceuticals has combined a 23.73% year to date share price return with a 21.28% 90 day share price gain, yet the 1 year total shareholder return declined 10.20%. This suggests that...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Tarsus Pharmaceuticals (TARS) Shares Just Moved, What Is Behind The Attention?

Why Tarsus Pharmaceuticals stock is in focus after Q2 2026 Tarsus Pharmaceuticals (TARS) is back on investors radar after its Q2 2026 earnings report showed higher revenue, a smaller net loss, and a higher full year sales outlook for XDEMVY. See our latest analysis for Tarsus Pharmaceuticals. Tarsus Pharmaceuticals shares have reacted positively to the Q2 2026 update, with a 17.99% 1 month share price return and a 15.21% 3 month share price return, while the year to date share price is still...
NYSE:BXC
NYSE:BXCTrade Distributors

3 U.S. Industrials That Could Gain If Tariffs Hit Canadian Metals And Lumber

With the clock ticking on potential 50% U.S. tariffs on Canadian goods, investors are watching domestic industrials in a new light. Companies with U.S. heavy operations and lower Canada revenue exposure could face a very different trade impact than cross border peers, for better or worse. This article walks through 3 stocks from that group and explains how the current tariff standoff might affect each one. The sample of stocks below is only a starting point, since the full screen surfaced 61...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Stronger Q1 Earnings and Higher Dividend Target Could Be A Game Changer For Hamilton Lane (HLNE)

Hamilton Lane’s August 4, 2026 report showed first‑quarter revenue of US$275.33 million and net income of US$80.46 million, with basic earnings per share from continuing operations of US$1.94, all higher than the same period a year earlier. At the same time, the company declared a quarterly dividend of US$0.60 per Class A share, lifting its full‑year dividend target by 11%, which underscores management’s confidence in current cash flows and capital‑return capacity. We’ll now examine how this...
NYSE:KVYO
NYSE:KVYOSoftware

Should Klaviyo’s (KVYO) Strong Q2, Raised Guidance and AI Agency Deal Prompt Investor Reassessment?

Klaviyo, Inc. reported past second-quarter 2026 results with revenue of US$370.58 million and a narrower net loss of US$8.85 million, while also issuing higher full-year revenue guidance and confirming third-quarter expectations. The company is pairing this improved financial profile with AI-focused expansion, acquiring Agency’s team and technology and appointing founder Elias Torres as Chief Product Officer to accelerate its agent product line. We’ll now examine how Klaviyo’s raised...
NasdaqGS:AUGO
NasdaqGS:AUGOMetals and Mining

Aura Minerals (NasdaqGS:AUGO) Shares Jumped, What Is Behind The Move?

Aura Minerals (AUGO) just reported quarterly and half year results that show higher sales and a sharp swing to profit, while also reaffirming its 2026 production targets to give investors clearer visibility. See our latest analysis for Aura Minerals. The strong earnings release, dividend declaration and recent buyback have come alongside a sharp move in Aura Minerals' stock, with a 30 day share price return of 56.39% and a one year total shareholder return of 188.55% signalling strong...
NYSE:RES
NYSE:RESEnergy Services

Oil Stocks To Watch As Brent Nears $90 And Supply Risks Return

Oil is back in the spotlight as Brent edges toward US$90, inflation worries return and war with Iran keeps traders on alert about global supply. At the same time, higher US Treasury yields are pressuring valuations while strong earnings keep stocks near record highs. This article walks through 3 large energy producers that screens suggest are most exposed to this mix of rising crude, rates and profit expectations. The 3 stocks below are just a starting sample, and the full screen surfaced 8...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

US$675 Million Refinancing Could Be A Game Changer For Chefs' Warehouse (CHEF)

The Chefs' Warehouse, Inc. previously began a refinancing process, marketing and later upsizing a new US$675 million term loan facility to refinance existing debt, redeem convertible notes, fund capital expenditures, and support general corporate purposes. This prospective refinancing could meaningfully reshape the company’s capital structure by consolidating borrowings into a single term loan while potentially extending maturities and increasing financial flexibility. We’ll now examine how...
NYSE:HGTY
NYSE:HGTYInsurance

Hagerty (HGTY), What Is Behind The Fresh Attention Today?

Hagerty (HGTY) is back in focus after its Broad Arrow unit reported record results at The Quail Auction, along with raised full year revenue and earnings guidance that contrasted with mixed second quarter figures. See our latest analysis for Hagerty. Hagerty shares trade at US$12.86 after a slight 1-day decline in the share price return of 0.85%, although a 16.38% 90-day share price return and a 46.30% three-year total shareholder return suggest momentum has been building over time. If this...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

Is Strong Q2, Higher 2026 Guidance and Heavy Buybacks Altering The Investment Case For Apple Hospitality REIT (APLE)?

Apple Hospitality REIT, Inc. recently reported its second-quarter 2026 results, with sales of US$365.17 million, revenue of US$402.55 million and net income of US$67.08 million, all higher than the same period a year earlier, and modestly improved earnings per share from continuing operations. Alongside these results, the company raised its full-year 2026 net income guidance by US$10 million at the midpoint and outlined US$85 million to US$95 million of capital investments focused on...
NYSE:CQP
NYSE:CQPOil and Gas

Should Stronger Q2 2026 Earnings and Profitability Trends at Cheniere (CQP) Require Action From Investors?

In August 2026, Cheniere Energy Partners, L.P. reported past second-quarter 2026 results showing revenue of US$2,583 million and net income of US$1,161 million, with basic earnings per share from continuing operations of US$2.14, all higher than the same period a year earlier. For the first half of 2026, the partnership’s revenue rose to US$6,183 million and net income to US$1,347 million, indicating stronger profitability and higher earnings per unit compared with the prior-year...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Marvell Stock And 2 AI Chip Plays Facing A Valuation Reset

AI related stocks have surged into the spotlight again after the ECB warned that the current rally in US tech valuations is edging into territory linked with past bubbles. That creates both risk and opportunity for anyone with exposure to AI heavy benchmarks. This article walks through 3 large cap AI and semiconductor leaders from our screener that could be especially sensitive if a sharp AI revaluation occurs. The stocks covered below are just a starting sample from this theme. The full...
NYSE:CRGY
NYSE:CRGYOil and Gas

Should Crescent’s Higher 2026 Output Targets and Steady Dividend Policy Require Action From CRGY Investors?

Crescent Energy recently raised its full-year 2026 production guidance, now targeting 327,000 to 335,000 barrels of oil equivalent per day, and confirmed a total quarterly dividend of US$0.12 per share with an ex-dividend date of August 17, 2026. This combination of higher expected output and a sustained dividend policy sharpens the focus on how Crescent balances growth with long-term payout support. We will now examine how the upgraded production guidance reshapes Crescent Energy’s...
NYSE:FDX
NYSE:FDXLogistics

Should FedEx’s (FDX) Automation and Cost Cuts Strategy Require Action From Investors?

In recent months, FedEx has pursued further automation with robotic loading systems and continued cost-cutting through facility closures and workforce reductions, aiming to improve network efficiency and cash generation. This combination of technology investment and restructuring highlights a tension between potential long-term productivity gains and the risk that aggressive cost measures could affect service quality and operational execution. Against this backdrop, we’ll explore how FedEx’s...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Is Revolution Medicines (RVMD) Fully Valued After Its BeOne Collaboration Deal?

Revolution Medicines (RVMD) drew investor attention after announcing a multi part collaboration with BeOne Medicines. The deal covers joint clinical studies on RAS(ON) inhibitors and grants BeOne exclusive development and commercialization rights in select Asian markets. See our latest analysis for Revolution Medicines. The BeOne Medicines news lands at a time when Revolution Medicines has already seen strong share price momentum, including a 13.88% 1 month share price return and a year to...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Does Halozyme’s Raised 2026 Revenue Outlook And Aggressive Buybacks Change The Bull Case For HALO?

In August 2026, Halozyme Therapeutics reported past second-quarter 2026 results showing revenue of US$481.00 million and net income of US$229.91 million, alongside higher earnings per share and the completion of share repurchases totaling 13,452,356 shares for US$750.00 million across two programs. The company also raised its 2026 total revenue guidance to a range of US$1.84 billion to US$1.91 billion, indicating management’s increased confidence after strong first-half performance and...
NYSE:QTWO
NYSE:QTWOSoftware

How Investors Are Reacting To Q2 Holdings (QTWO) Slower Billings Growth And Rising Servicing Costs

Recently, analysis of Q2 Holdings highlighted that its cloud-based digital banking platform is now facing slower average billings growth alongside elevated servicing costs. This shift, occurring despite the company remaining profitable, raises fresh questions about how efficiently Q2 can scale its business model over time. We’ll now examine how concerns over slowing billings growth could reshape Q2 Holdings’ broader investment narrative for investors. Find 53 companies with promising cash...
NYSE:AIN
NYSE:AINMachinery

Stronger Q2 Results and Buybacks Might Change The Case For Investing In Albany International (AIN)

Albany International Corp. recently reported past second-quarter 2026 results showing higher sales of US$329.48 million and net income of US$17.41 million, alongside completing a US$173.36 million share repurchase program that retired 2,682,859 shares. The company also issued third-quarter 2026 revenue guidance of US$320 million to US$330 million, giving investors a clearer view of near-term operating momentum and capacity to generate earnings from continuing operations. With this...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Willdan Group (WLDN) Following Q2 Results And 2026 Targets Has An Undervalued Narrative

Willdan Group (WLDN) stock is in focus after the company reported second quarter 2026 results alongside full year revenue targets. Investors are assessing what the updated figures mean for the business. See our latest analysis for Willdan Group. At a share price of $83.47, Willdan Group has seen its share price return rise about 15% over the past month but decline around 22% year to date, while three year total shareholder return is above 2.5x. This suggests recent momentum is building again...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

Will GigaCloud’s (GCT) New Buyback, Guidance and M&A Plans Reshape Its Capital Allocation Narrative?

In early August 2026, GigaCloud Technology Inc. reported second-quarter 2026 results with higher revenue and net income year over year, issued third-quarter revenue guidance of US$375 million to US$400 million, extended its share repurchase plans, and signalled interest in further acquisitions once its New Classic integration progresses. Together, these earnings, buyback, and M&A updates highlight GigaCloud’s focus on scaling its B2B e-commerce platform while actively returning capital to...
NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

Data Center Power Stocks Retail Investors Are Watching As AI Energy Demand Grows

Coordinated policy moves to support growth, curb inflation, and secure energy supplies have pushed data-center power and cooling from a back-room utility to a front-page investment story. When governments focus on electrification and resilient infrastructure, capital often follows. This article examines what that could mean for data-center infrastructure stocks that are influenced by these policy trends and highlights 3 companies from our screener that may be positioned to benefit. The three...
NasdaqGS:APA
NasdaqGS:APAOil and Gas

Is APA’s Higher 2026 Output Guidance Altering The Investment Case For APA (APA)?

APA Corporation recently reported its second-quarter 2026 results, showing lower year-on-year production and revenue but higher net income of US$747 million and earnings per share of US$2.11. Shortly after, the company raised its 2026 full-year oil production guidance to 123,000 barrels per day from 120,000, underscoring management’s confidence in its operating plans despite softer recent volumes. Now we’ll consider how the higher 2026 oil production guidance could reshape APA’s previously...
NYSE:MPT
NYSE:MPTHealth Care REITs

The Bull Case For Medical Properties Trust (MPT) Could Change Following Near Breakeven Q2 Results And Maintained Dividend

In August 2026, Medical Properties Trust reported second-quarter results showing revenue of US$259.28 million and a much smaller net loss of US$2.6 million, alongside a Board-approved regular quarterly dividend of US$0.09 per share to be paid in October. The sharp year-on-year improvement from a US$98.36 million net loss to near break-even, and a swing to US$30.23 million net income for the first half, highlights how recent operational and financial adjustments are feeding into the REIT’s...